Zheng, J., Yu, J., Yang, M., & Tang, L. (2019). Gefitinib suppresses cervical cancer progression by inhibiting cell cycle progression and epithelial-mesenchymal transition. Exp Ther Med.
Styl ChicagoZheng, Jianyun, Jianxin Yu, Min Yang, a Li Tang. "Gefitinib Suppresses Cervical Cancer Progression By Inhibiting Cell Cycle Progression and Epithelial-mesenchymal Transition." Exp Ther Med 2019.
Citace podle MLAZheng, Jianyun, Jianxin Yu, Min Yang, a Li Tang. "Gefitinib Suppresses Cervical Cancer Progression By Inhibiting Cell Cycle Progression and Epithelial-mesenchymal Transition." Exp Ther Med 2019.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..